26 Chapter 1 85. Leonetti A, Wever B, Mazzaschi G, Assaraf YG, Rolfo C, Quaini F, et al. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. Drug Resistance Updates. 2019;46:100644. 86. Infante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, et al. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. American journal of respiratory and critical care medicine. 2015;191(10):1166-75. 87. Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, et al. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67(4):296-301. 88. Pastorino U, Rossi M, Rosato V, Marchiano A, Sverzellati N, Morosi C, et al. Annual or biennial CT screening versus observation in heavy smokers. European Journal of Cancer Prevention. 2012;21(3):308-15. 89. de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume CT screening in a randomized trial. New England journal of medicine. 2020;382(6):503-13. 90. McLean AEB, Barnes DJ, Troy LK. Diagnosing Lung Cancer: The Complexities of Obtaining a Tissue Diagnosis in the Era of Minimally Invasive and Personalised Medicine. Journal of Clinical Medicine. 2018;7(7):163. 91. Nooreldeen R, Bach H. Current and Future Development in Lung Cancer Diagnosis. Int J Mol Sci. 2021;22(16). 92. Tipaldi MA, Ronconi E, Krokidis ME, Zolovkins A, Orgera G, Laurino F, et al. Diagnostic yield of CT-guided lung biopsies: how can we limit negative sampling? Br J Radiol. 2022;95(1130):20210434. 93. Mayo-de-las-Casas C, Jordana-Ariza N, Garzón-Ibañez M, Balada-Bel A, Bertrán-Alamillo J, Viteri-Ramírez S, et al. Large scale, prospective screening of EGFR mutations in the blood of advanced NSCLC patients to guide treatment decisions. Annals of Oncology. 2017;28(9):2248-55. 94. Janku F, Kurzrock R. Bringing Blood-Based Molecular Testing to the ClinicBlood-Based Molecular Testing. Clinical Cancer Research. 2016;22(22):5400-2.
RkJQdWJsaXNoZXIy MjY0ODMw